Lung Functions in Menopausal Obese Women After COVID 19 Recovery

Badr University

Status

Completed

Conditions

Menopause

Covid19

Obesity

Lung Function Decreased

Treatments

Device: Spirometry

Study type

Observational

Funder types

Other

Identifiers

NCT05008991

Hend 2

Details and patient eligibility

About

The COVID-19 pandemic has presented considerable challenges to global health services and dictates almost every aspect of medical practice and policy. The menopausal transition may have significant consequences for respiratory health as COVID 19 symptoms subsides, lung function testing should be done to assess the consequences of this virus on lung health especially in menopausal woman.

Full description

The study group will consist of (40) obese menopausal women whom were recently recovered from mild-moderate COVID 19 for one month. The control group will consist of (40) obese menopausal women; whom will not affected by COVID 19. Using incentive spirometer, we will measure forced vital capacity FVC, forced expiratory volume FEV, Tiffano index TI and peak expiratory force PEF in both groups.

Enrollment

40 patients

Sex

Female

Ages

45 to 55 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Participants recovered from mild to moderated signs and symptoms of COVID- 19 after one month.
Ability to perform pulmonary function tests correctly.
COVID-19 was diagnosed by positive polymerase chain reaction (PCR) testing on nasopharyngeal swab, oxygen saturation was ranged between 92-96% during illness period.
CT chest shows ground glass opacity.
Their D-dimer was less than 0.5 μg/ml.
Two successive negative PCR were before included in study.
Participants were in home isolation during illness period.

Exclusion criteria